Navigation Links
A*STAR scientist Alex Matter awarded prestigious Szent-Györgyi Prize for progress in cancer
Date:4/5/2013

1. Professor Alex Matter, Chief Executive Officer of A*STAR's Experimental Therapeutics Centre (ETC), has been awarded the 8th Annual Szent-Gyrgyi Prize for Progress in Cancer Research by the National Foundation for Cancer Research (NFCR) for his contributions to the development of the first drug specifically targeting a molecular lesion in cancer.

2. Professor Matter is a pioneer of the world's first targeted cancer therapy, imatinib mesylate, also known as Glivec[1]. His discovery turned chronic myeloid leukaemia (CML) from a deadly disease into one that can be treated with an oral pill with nearly 90% long-term survival rate, with little or no side-effects. Following Glivec's success in CML, it has been successfully applied to other malignant cancers. Professor Matter's groundbreaking research demonstrated that by specifically inhibiting the activity of key oncogenic cells, it is possible to counteract cancer at the molecular biology level.

3. Chairman of A*STAR's Biomedical Research Council (BMRC), Professor Sir George Radda said, "This award gives due recognition to Alex's significant work which revolutionised anti-cancer drug development and gave a boost to the fight against cancer globally. We are proud to have this luminary working hand-in-hand with us in A*STAR."

4. Professor Matter joined ETC in April 2009, bringing with him his expertise and experience in building bridges between academic research and clinical analysis. ETC now boasts a staff strength of around 80, many of whom are senior group leaders with industrial experience who are able to train young scientists in the rigour of drug discovery and development. Committed to nurturing the young scientists in this highly competitive field, Professor Matter said, "Young people need to be trained for successful and competitive drug discovery. We are training this young generation in drug discovery the way an industrial outfit works."'/>"/>

Contact: Dr. Sarah Chang
chang_kai_chen@a-star.edu.sg
656-826-6442
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. A*STAR scientists discover switch critical to wound healing
2. Singapore scientists led by A*STARs GIS identify 4 mechanisms that contribute to gastric cancers
3. A*STAR scientists identify potential drug target for inflammatory diseases including cancers
4. Fruit flies light the way for A*STAR scientists to pinpoint genetic changes that spell cancer
5. A*STAR scientists discover switch to boost anti-viral response to fight infectious diseases
6. Could Scientists Peek Into Your Dreams?
7. CWRU-led scientists build material that mimics squid beak
8. Singapore clinician-scientists identify new type of deadly lymphoma
9. Rocket Scientist develops the Ultimate Health & Fitness App
10. Kessler Foundation scientists receive Consortium of MS Centers grant to study emotional processing
11. Scientists identify brains molecular memory switch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... Sharenote, a leading web-base electronic healthcare software (EHR) is ... in Louisiana. The entrepreneurial trio behind Sharenote, will travel ... providers with the tools and resources to monitor key ... network. , Find out why Sharenote is the ... than 250 practices. , Four Day Schedule ...
(Date:6/1/2015)... There’s never a good time to be sick and need ... , As of June 1, OSF HealthCare is offering ... the Internet. Patients throughout Illinois can access care whenever they ... busy. We know that getting in to see a provider ... it easier,” said Jeffry Tillery, MD, Chief Transformation Officer for ...
(Date:6/1/2015)... Hexagon Geospatial is pleased to announce the launch ... service that provides on-demand access to the company’s world-class ... IMAGINE and GeoMedia are now available ... subscription model for delivering software products as an online ... quickly and easily access the right tools that help ...
(Date:6/1/2015)... June 01, 2015 Good360 announced ... the Irene W. and C.B. Pennington Foundation, Louisiana’s ... board of directors. Bertman joins Good360 just before ... this summer. , "Bringing with her many years ... am thrilled that Lori is joining the Good360 ...
(Date:6/1/2015)... Triple C announced today that they will be ... this year on RFD-TV. , From the humble, farm shop ... the today’s full line of rugged products, Triple C, Inc. ... , In this segment, American Farmer will explore how ... thrive in the tough conditions on North American ranches. Viewers ...
Breaking Medicine News(10 mins):Health News:OSF HealthCare Now Offering OSF OnCall 2Health News:OSF HealthCare Now Offering OSF OnCall 3Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 2Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 3Health News:Lori Bertman Joins Good360 Board of Directors 2Health News:Triple C to Be Featured in Upcoming Episode of American Farmer 2
... non-serious side effects , , FRIDAY June 27 (HealthDay News) ... marijuana plant don,t increase the risk of serious side ... non-serious side effects, Canadian scientists report. , The researchers ... British Columbia (UBC) examined adverse events reported in 31 ...
... (PTCB), the leading national program that has ... and congratulates the Florida House of Representatives ... requiring new standards for pharmacy technicians. The ... toward increasing patient safety for consumers. The ...
... /PRNewswire-FirstCall/,-- Schering-Plough Corp. (NYSE: SGP ) and ... the withdrawal of the New Drug Application (NDA) ... terminated the Schering-Plough/Merck Pharmaceuticals,respiratory joint venture, which was ... fixed-combination product that would combine loratadine and,montelukast. This ...
... 27 Health care facilities,in the U.S. are ... infections (HAI). Could there be hidden areas of,infection ... education program,from the production company Mission Critical attempts ... Areas of Infection,",( http://www.missioncriticaltv.com/index-8-1.html ) documents how an ...
... to the latest,report by the American Lung Association, Lung ... increasing while death rates due to other,leading causes of ... Chronic obstructive pulmonary disease (COPD) is expected to,become the ... American Lung Association publishes Lung Disease Data to serve ...
... a World Health Organization expert on E. coli ... Bioniche Life Sciences,Inc. (TSX: BNC), a research-based, technology-driven ... this week,entitled, "E. coli O157 Vaccine: Added Value ... from the food industry: Beef,dairy, and other agricultural ...
Cached Medicine News:Health News:Drugs With Marijuana Compounds Don't Boost Adverse Events 2Health News:Pharmacy Technician Certification Board (PTCB) Supports Florida's New Patient Safety Solution 2Health News:Pharmacy Technician Certification Board (PTCB) Supports Florida's New Patient Safety Solution 3Health News:Hidden Areas of Infection in U.S. Hospitals 2Health News:Hidden Areas of Infection in U.S. Hospitals 3Health News:American Lung Association Report Finds Lung Disease Death Rates Increasing While Cancer, Heart Disease and Stroke Death Rates Are Decreasing 2Health News:American Lung Association Report Finds Lung Disease Death Rates Increasing While Cancer, Heart Disease and Stroke Death Rates Are Decreasing 3Health News:Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference 2Health News:Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference 3Health News:Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference 4Health News:Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference 5
(Date:6/1/2015)... May 29, 2015 Research and Markets ... the "Global A Dialyzer Reprocessing Machine (A ... to their offering. The Global A ... Report 2014 is a professional and in-depth study ... reprocessing machine industry. The report provides a ...
(Date:6/1/2015)...  Boston Biomedical, an industry leader in the development ... (CSC) pathways, will present clinical data today on the ... at the 2015 American Society of Clinical Oncology (ASCO) ... Data presented at ASCO highlight the potential of ... leading to inhibition of the critical genes for maintaining ...
(Date:6/1/2015)... , June 1, 2015   OTC ... Open, Transparent and Connected financial marketplaces for 10,000 ... a San Diego -based biopharmaceutical ... on OTCQB®, America,s only public venture market for ... - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO "We,re ...
Breaking Medicine Technology:Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor) Industry Report 2014 - Development Trends Forecasts to 2020 2Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor) Industry Report 2014 - Development Trends Forecasts to 2020 3Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 2Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 3Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 4Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 5Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 6Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 7OTC Markets Group Congratulates OncoSec Medical on NASDAQ Listing 2
... DIEGO, Dec. 20, 2010 Optimer Pharmaceuticals, Inc. ... Gregory Papaz has joined Optimer as Senior Vice ... the preparations for the planned commercialization of fidaxomicin. ... of experience in the healthcare and pharmaceutical industry ...
... XI,AN, China, Dec. 20, 2010 /PRNewswire-Asia-FirstCall/ -- DK Sinopharma, Inc. (OTC ... was honored at a grand awards ceremony on December 8, 2010 ... Paying Credit Rating on September 30, 2010. "We ... third time in a row that the Company has been rated ...
Cached Medicine Technology:Optimer Pharmaceuticals Appoints Gregory Papaz to New Position of Senior Vice President of Commercial Operations 2Optimer Pharmaceuticals Appoints Gregory Papaz to New Position of Senior Vice President of Commercial Operations 3DK Sinopharma, Inc. is Honored as 'A-class Taxpayer' for the Third Time 2DK Sinopharma, Inc. is Honored as 'A-class Taxpayer' for the Third Time 3
The most compact revolutionary innovation in hematology. 3 Part DIFF + CRP measurement on whole blood....
... a compact, stand-alone microprocessor-controlled photometer designed to ... microplates using single- or dual- wavelength reading ... a dynamic reading range up to 4.0 ... laboratory or assay requirements. Self-diagnostics (up to ...
... has revolutionized the treatment of the upper ... construct was used in the developmemt of ... the tibia, with its limited blood supply ... to the healing process. The fluted, tapered, ...
... offers a disposable alternative to the proven ... clears bone and cement debris during total ... hip and knee applications. Variety of ... options for soft tissue treatment. Low power ...
Medicine Products: